NextFin News - A little-known Czech investment fund with a $23.15 million stake is telling Xerox Holdings Corp. what to do with one of the most recognizable names in corporate America — and its math says the printer maker's financing arm alone is worth more than the entire company. STARTEEPO SICAV, led by investor Frantisek Bostl, disclosed a 7.34% position in Xerox on Sept. 8, 2026, becoming the office-technology company's third-largest shareholder after BlackRock and Vanguard, and handed the board a plan to unlock what it calls trapped value: separate the financial-services unit, bring in outside capital, and cut debt. Xerox shares jumped as much as 6.9% to $3.55 in early New York trading on the news before paring back to close at $3.20. The question underneath the pop is sharper than the headline: is Xerox's problem a broken business, or a broken balance sheet that financial engineering can fix?
The $23 Million Stake and the $7.69 Claim
The campaign arrived in a Sept. 7 letter to the Xerox board, released publicly the next day alongside an investor presentation. Bostl's argument is a classic sum-of-the-parts pitch dressed in balance-sheet language. STARTEEPO values Xerox Financial Services — the unit that lends to customers buying Xerox equipment and leases machines to end users — at between $1.3 billion and $1.5 billion, or roughly $7.69 per share. That is more than double where the whole stock traded before the announcement. Put the pieces together, STARTEEPO argues, and a deleveraged, re-rated Xerox could reach $3.3 billion in equity value, or more than $18 a share.
The filing behind the campaign is specific. In an amended Schedule 13D, STARTEEPO SICAV reported beneficial ownership of 8 million shares, or 6.09% of Xerox's outstanding common stock. Bostl, who serves as the fund's chairman and chief investment officer, holds an additional 1.5 million shares directly plus call options on 140,000 more, bringing his aggregate beneficial ownership to 9.64 million shares, or 7.34%. The reporting persons paid an aggregate $23.15 million for the position — $22.96 million in common stock and $192,000 in option premiums — against 131.3 million shares outstanding as of July 31, 2026.
This was not a sudden entry. STARTEEPO first disclosed its Xerox position in May, filing a Schedule 13D on May 14 showing a 5.15% stake of about 6.6 million shares acquired for roughly $14.2 million. It kept buying through the summer: between July 9 and July 10 alone it added 800,000 shares at prices of $2.78 to $2.81, and raised its holding above 6% ahead of Xerox's second-quarter earnings in late July. By the time the letter landed, the fund had more than doubled its original check while the stock sat well below its 52-week high of $4.27.
The demands are concrete and sequenced. First, Xerox should disclose the financial-services unit's results separately in its earnings reports and lay out a strategy for the business by its third-quarter results. Second, it should hire advisers to run a formal strategic review of the unit, with options including a joint venture, a strategic capital partnership, partial monetization, or an outright sale. Third, the company should keep deleveraging and adopt a more disciplined approach to capital allocation. The centerpiece is what STARTEEPO calls an "optimized capital structure": a third party would provide the funding for the finance portfolio while Xerox keeps the servicing infrastructure and customer relationships — a model Bostl says peers such as HP and General Electric already use.
Xerox's public response has been measured. On its investor-relations page, the company acknowledged the amended filing and said it "will review and consider input from shareholders as part of our commitment to disciplined execution and long term value creation," while reiterating its priorities of stabilizing revenue, increasing profitability, and reducing leverage. The company entered 2026 with what it called improving momentum, reinforced by a positive first quarter.
The Mechanism: Why the Balance Sheet Is the Bottleneck
Start with the numbers that make the activist's case plausible. Xerox's total debt stood at $4.2 billion at the end of the second quarter. Gross leverage was 5.9 times trailing 12-month EBITDA, down from 7 times the prior quarter; net leverage fell to 5.1 times from 6 times. Those are high multiples for a company in a structurally declining print market, and they are the direct consequence of the Lexmark acquisition, which closed late last year and added both revenue and debt in the same stroke. Second-quarter revenue rose 22% to $1.92 billion on the Lexmark contribution, though on a pro forma basis — comparing the combined company against itself — revenue fell 6.5%.
Here is the transmission channel that matters. A heavily leveraged balance sheet does three damaging things at once. It forces a large chunk of operating cash flow into interest payments rather than growth investment or debt paydown — non-financing interest expense jumped to $100 million in the second quarter from $55 million a year earlier. It compresses the equity multiple because investors discount a stream of earnings that is already pledged to creditors. And it narrows management's option set: with creditors watching, a company cannot easily fund the very finance receivables that drive its equipment sales.
That last point is where Xerox Financial Services becomes more than a footnote. The unit exists to make it easier for customers to buy Xerox hardware — financing is the grease in the equipment-sales engine. But if Xerox's own cost of capital is elevated because of its leverage, funding that receivable book on its own balance sheet is expensive. Selling or partnering on the portfolio, as STARTEEPO proposes, would transfer the funding cost to a counterparty with a cheaper balance sheet while Xerox retains the customer relationship and servicing fees. The equity release is immediate: proceeds from a sale or partnership go straight to debt reduction, leverage falls, and the remaining earnings stream is re-rated.
Xerox is already moving on debt, just not as fast as the activist would like. The company reduced total debt by $223 million in the second quarter alone, and management said it has used about $101 million in cash year to date to retire $200 million of debt in the open market, capturing a $99 million discount. Its updated guidance implies gross leverage falling from 7.0 times in the first quarter to 4.9 times by year-end, assuming no additional open-market repurchases.
Ultimately, we see a deleveraged and re-rated Xerox as better able to participate in industry consolidation and command a premium valuation.
Bostl wrote in the letter.
The fund also acknowledged management's progress:
By every measure, the business has improved in the past four months.
The complaint is not that operations are failing. It is that the capital structure is swallowing the improvement.
The market heard the argument. Xerox rose as much as 6.9% to $3.55 on Sept. 8, closing at $3.20, then traded between $3.08 and $3.46 over the following three sessions, finishing the week at $3.43. Against a market capitalization of roughly $420 million at the time of the campaign, a move of that size represents a meaningful repricing of a micro-cap name — but it still leaves the stock far below STARTEEPO's $18 target.
Cyclical or Structural? Two Different Problems, Two Different Fixes
The central analytical question is whether Xerox's discount is cyclical — a temporary mispricing that mean-reverts once the balance sheet heals — or structural, a permanent re-rating of a business whose core market is shrinking. The answer, uncomfortably, is both, and STARTEEPO's pitch depends on treating them as separable.
The cyclical leg is the balance sheet itself. Leverage at 5.9 times EBITDA is not a permanent condition; it is the artifact of a single transaction, the Lexmark deal. Xerox is already paying it down, and if debt paydown continues and the integration delivers the promised synergies, the multiple can compress without any change in the underlying business model. This is the mean-reverting part of the story, and it is the part where financial engineering has genuine leverage.
The structural leg is the print business. Equipment sales, the highest-margin hardware line, fell 13% on a pro forma basis in the second quarter. Post-sale revenue — the annuity-like stream of supplies, service, and maintenance that has historically funded these companies — declined 4% pro forma. And Xerox Financial Services revenue itself fell 20.3% year over year in the second quarter to $55 million, following a 22.8% drop in the first quarter, driven by a lower average finance receivable balance. These are not cyclical dips; they reflect a secular shift away from paper and owned hardware toward digital workflows and subscription models.
The distinction matters because it determines what the activist fix can and cannot do. If the problem were purely cyclical — a good business with too much debt — then STARTEEPO's plan works cleanly: monetize the finance book, cut debt, re-rate the equity. If the problem is structural, the same plan still works in the near term but buys time rather than a cure. Separating XFS extracts value from a shrinking asset before it shrinks further; it does not reverse the decline in equipment demand. The sum-of-the-parts math captures value that exists today; it does not create a growth engine.
So the correct read is a barbell: a near-term cyclical re-rating driven by balance-sheet repair, sitting on top of a long-term structural decline in the legacy print franchise. The activist's $18 target prices the first leg aggressively and assumes the second leg can be managed rather than reversed. That assumption is the fulcrum of the whole thesis.
The Counter-Thesis: A Shrinking Finance Book and the Ghost of Activists Past
The strongest case against STARTEEPO starts with the asset it wants to monetize. Xerox Financial Services is not a standalone growth company; it is a captive finance arm whose fortunes are tied to Xerox equipment sales. A joint-venture partner or portfolio buyer will underwrite the receivables based on the credit quality of Xerox's customer base and the residual value of the leased machines — both of which deteriorate if hardware volumes keep falling. The roughly 20% year-over-year revenue decline in the unit is a warning sign for any buyer: you are purchasing a book that is shrinking, at a price that assumes it is stable.
There is also the question of whether the market has simply been here before. Carl Icahn, one of the most prominent activists of his generation, took on Xerox starting in 2015. He pushed for strategic alternatives and operational improvements, secured three board seats after Xerox announced a split of its hardware and services operations, and ultimately sold his remaining stake back to the company for $542 million in 2023. The company has been through the activist playbook — board pressure, strategic reviews, separation plans — and the stock still trades in the low single digits. A skeptic would argue that Xerox's discount is not a puzzle waiting for the right financial engineer; it is the market's considered verdict on a business whose best years are behind it.
Then there is the execution risk embedded in the plan itself. An "optimized capital structure" sounds clean in a presentation. In practice, it requires finding a counterparty willing to fund a declining receivable book at attractive terms, negotiating a servicing agreement that preserves Xerox's economics, and executing the transaction without disrupting the equipment-sales engine that the finance unit supports. Xerox's own management has spent two years arguing that integration and deleveraging are the priorities; a proxy fight or a drawn-out review process would divert attention and could delay the very debt paydown both sides say they want.
Even the valuation math has a soft underbelly. STARTEEPO's $7.69-per-share figure for XFS is an estimate, not a bid. Until a buyer puts down a number, it is a claim about what the market should recognize, not what it will pay. And the $18 target assumes the remaining industrial business earns a premium multiple after deleveraging — a generous assumption for a hardware company with pro forma revenue declines in both equipment and post-sale lines.
The falsifying signal is observable and near-term. Xerox is due to report third-quarter results in late October. If management declines to provide separate XFS disclosure or to engage advisers on a strategic review by that report, or if the unit's revenue decline accelerates beyond the roughly 20% pace seen in the first half of 2026, the sum-of-the-parts thesis loses its two supporting pillars: a valuable separable asset and a cooperative board. Conversely, if Xerox announces a partnership or partial monetization of XFS alongside continued debt reduction, the re-rating argument moves from presentation math toward realization.
What to Watch Next
The near-term catalyst is the third-quarter earnings report, where STARTEEPO has asked management to communicate its XFS strategy and provide separate unit financials. The company has said it will review shareholder input, but the gap between "review and consider" and "hire advisers and launch a formal process" is where this campaign will be won or lost.
Three scenarios frame the path ahead. In the base case, Xerox engages constructively, adds some form of XFS disclosure, and continues paying down debt; the stock grinds higher as leverage falls but stops well short of $18 because the structural print decline caps the multiple. In the upside case, the company appoints advisers, announces a joint venture or partial sale of the finance portfolio, and uses the proceeds to accelerate deleveraging — the conditions under which STARTEEPO's sum-of-the-parts math could partially materialize. In the downside case, management resists, the finance book's decline accelerates, and the stock drifts back toward its pre-announcement lows as investors conclude that the activist's plan is another round of a familiar and exhausted playbook.
The time-horizon split is clean. Over the next quarter, sentiment and the earnings response will dominate. Over the next year, the debt trajectory and any XFS transaction will set the range. Over the long term, the question is whether Xerox can build a business that does not depend on selling more printers — and no balance-sheet fix answers that.
Xerox's problem is not that it lacks value. It is that its value is trapped in a capital structure built for a company it no longer is. STARTEEPO's plan can spring that trap — but only if the asset inside is worth more to someone else than it is to Xerox, and only if the market decides a Czech fund with a $23 million check has found something that Carl Icahn, with board seats and half a billion dollars, could not.
Explore more exclusive insights at nextfin.ai.
